lodenosine has been researched along with HIV in 7 studies
*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, S; Barchi, JJ; Driscoll, JS; Ford, H; Kelley, JA; Marquez, VE; Mitsuya, H; Shirasaka, T | 1 |
| Aoki, S; Broder, S; Driscoll, JS; Ford, H; Johns, DG; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Tseng, CK | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Herdewijn, P; Pauwels, R | 1 |
| Driscoll, JS; Ford, H; Kelley, JA; Marquez, VE; Mitsuya, H; Roth, JS; Siddiqui, MA; Tanaka, M | 1 |
| Ahluwalia, GS; Cooney, DA; Driscoll, JS; Johns, DG; Mitsuya, H; Shirasaka, T | 1 |
| Ford, H; Kelley, JA; Mitsuya, H; Roth, JS; Tanaka, M | 1 |
| Gao, YG; Liaw, YC; Marquez, VE; Wang, AH | 1 |
7 other study(ies) available for lodenosine and HIV
| Article | Year |
|---|---|
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs.
Topics: Adenosine Deaminase; Antiviral Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV; Kinetics; Prodrugs; Structure-Activity Relationship | 1991 |
Acid-stable 2'-fluoro purine dideoxynucleosides as active agents against HIV.
Topics: Antiviral Agents; Drug Stability; Gene Products, gag; HIV; HIV Core Protein p24; Lymphocyte Activation; Purine Nucleosides; Viral Core Proteins | 1990 |
Synthesis and anti-HIV activity of various 2'- and 3'-substituted 2',3'-dideoxyadenosines: a structure-activity analysis.
Topics: Antiviral Agents; Deoxyadenosines; Dideoxyadenosine; HIV; Structure-Activity Relationship | 1987 |
Lipophilic, acid-stable, adenosine deaminase-activated anti-HIV prodrugs for central nervous system delivery. 3. 6-Amino prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine.
Topics: Adenosine Deaminase; Antiviral Agents; Brain; Didanosine; HIV; Humans; Hydrolysis; Prodrugs; Solubility | 1996 |
Enhancement by 2'-deoxycoformycin of the 5'-phosphorylation and anti-human immunodeficiency virus activity of 2',3'-dideoxyadenosine and 2'-beta-fluoro-2',3'-dideoxyadenosine.
Topics: Adenosine Deaminase Inhibitors; Cell Line; Didanosine; Dideoxyadenosine; Drug Synergism; HIV; IMP Dehydrogenase; Pentostatin; Phosphorylation; Ribavirin | 1994 |
Determination of 2'-beta-fluoro-2',3'-dideoxyadenosine, an experimental anti-AIDS drug, in human plasma by high-performance liquid chromatography.
Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Blood Proteins; Chromatography, High Pressure Liquid; Dideoxyadenosine; Drug Stability; HIV; HIV Seropositivity; Humans; Protein Binding; Reproducibility of Results; Spectrophotometry, Ultraviolet | 1998 |
Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)hypoxanthine.
Topics: Antiviral Agents; Didanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Molecular Structure; Structure-Activity Relationship; X-Ray Diffraction | 1992 |